Membranes for Guided Bone Regeneration: A Road from Bench to Bedside

被引:181
作者
Aprile, Paola [1 ]
Letourneur, Didier [1 ]
Simon-Yarza, Teresa [1 ]
机构
[1] Univ Sorbonne Paris Nord, Univ Paris, X Bichat Hosp, LVTS INSERM U1148, F-75018 Paris, France
关键词
biomaterials; bone tissue engineering; medical device regulations; preclinical studies; quality by design; MESENCHYMAL STEM-CELLS; OF-THE-ART; VERTICAL RIDGE AUGMENTATION; BIPHASIC CALCIUM-PHOSPHATE; TISSUE REGENERATION; BARRIER MEMBRANES; CROSS-LINKING; EXTRACELLULAR-MATRIX; COLLAGEN MEMBRANE; CLINICAL-OUTCOMES;
D O I
10.1002/adhm.202000707
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Bone resorption can negatively influence the osseointegration of dental implants. Barrier membranes for guided bone regeneration (GBR) are used to exclude nonosteogenic tissues from influencing the bone healing process. In addition to the existing barrier membranes available on the market, a growing variety of membranes for GBR with tailorable physicochemical properties are under preclinical evaluation. Hence, the aim of this review is to provide a comprehensive description of materials used for GBR and to report the main industrial and regulatory aspects allowing the commercialization of these medical devices (MDs). In particular, a summary of the main attributes defining a GBR membrane is reported along with a description of commercially available and under development membranes. Finally, strategies for the scaling-up of the manufacturing process and the regulatory framework of the main MD producers (USA, EU, Japan, China, and India) are presented. The description of the regulatory approval process of GBR membranes is representative of the typical path that medium- to high-risk MDs have to follow for an effective medical translation, which is of fundamental importance to increase the impact of biomedical research on public health.
引用
收藏
页数:24
相关论文
共 202 条
[1]  
Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
[2]  
Aitchison G A, 2009, Open Biomed Eng J, V3, P21, DOI 10.2174/1874120700903010021
[3]  
Almutairi Abdullah S, 2018, F1000Res, V7, P685, DOI 10.12688/f1000research.14939.1
[4]  
[Anonymous], 2018, OV DEV REG
[5]  
[Anonymous], 2019, MED DEV CONT MAT DER
[6]   Product life cycle cost analysis: state of the art review [J].
Asiedu, Y ;
Gu, P .
INTERNATIONAL JOURNAL OF PRODUCTION RESEARCH, 1998, 36 (04) :883-908
[7]   The use of extracellular matrix as an inductive scaffold for the partial replacement of functional myocardium [J].
Badylak, Stephen F. ;
Kochupura, Paul V. ;
Cohen, Ira S. ;
Doronin, Sergey V. ;
Saltman, Adam E. ;
Gilbert, Thomas W. ;
Kelly, Damon J. ;
Ignotz, Ronald A. ;
Gaudette, Glenn R. .
CELL TRANSPLANTATION, 2006, 15 :S29-S40
[8]   Esophageal Preservation in Five Male Patients After Endoscopic Inner-Layer Circumferential Resection in the Setting of Superficial Cancer: A Regenerative Medicine Approach with a Biologic Scaffold [J].
Badylak, Stephen F. ;
Hoppo, Toshitaka ;
Nieponice, Alejandro ;
Gilbert, Thomas W. ;
Davison, Jon M. ;
Jobe, Blair A. .
TISSUE ENGINEERING PART A, 2011, 17 (11-12) :1643-1650
[9]   Quality-by-design of nanopharmaceuticals - a state of the art [J].
Bastogne, Thierry .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2017, 13 (07) :2151-2157
[10]   Evaluation of autogenous PRGF plus -TCP with or without a collagen membrane on bone formation and implant osseointegration in large size bone defects. A preclinical invivo study [J].
Batas, Leonidas ;
Stavropoulos, Andreas ;
Papadimitriou, Serafim ;
Nyengaard, Jens R. ;
Konstantinidis, Antonios .
CLINICAL ORAL IMPLANTS RESEARCH, 2016, 27 (08) :981-987